Anti-IRS4 antibody [EP907Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Recombinant Monoclonal IRS4 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 9 publications.
View Alternative Names
Insulin receptor substrate 4, IRS-4, 160 kDa phosphotyrosine protein, Phosphoprotein of 160 kDa, py160, pp160, IRS4
- IP
Lab
Immunoprecipitation - Anti-IRS4 antibody [EP907Y] (AB52622)
Purified ab52622 at 1/20 dilution (0.5μg) immunoprecipitating IRS4 in HEK-293 whole cell lysate.
Lane 1 (input) : HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab52622 + HEK-293 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab52622 in HEK-293 whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 133 kDa
All lanes:
Immunoprecipitation - Anti-IRS4 antibody [EP907Y] (ab52622)
Predicted band size: 134 kDa
false
- WB
Unknown
Western blot - Anti-IRS4 antibody [EP907Y] (AB52622)
Blocking buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-IRS4 antibody [EP907Y] (ab52622) at 1/10000 dilution
All lanes:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 134 kDa
Observed band size: 133 kDa
false
Related conjugates and formulations (1)
-
Anti-IRS4 antibody [EP907Y] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The role of IRS4 extends beyond signal transduction. It participates in the regulation of growth survival and metabolism. Although not part of a permanent protein complex IRS4 temporarily binds to receptors and adaptor proteins during signal transduction processes. The interactions allow IRS4 to integrate signals from different receptors to produce coordinated cellular responses particularly in energy homeostasis and glucose metabolism.
Pathways
IRS4 serves important functions in the insulin signaling and growth hormone signaling pathways. Within the insulin signaling pathway IRS4 acts as a central node linking insulin receptors to the activation of phosphoinositide 3-kinase (PI3K) which subsequently leads to activation of protein kinase B (AKT) and mitogen-activated protein kinase (MAPK) pathways. Related proteins in these cascades include other insulin receptor substrates such as IRS1 and IRS2 which share overlapping roles but may exhibit tissue-specific functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
npj metabolic health and disease 3:8 PubMed40052110
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 12:3131-3144 PubMed32440211
2020
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 8:3643-3653 PubMed30026872
2018
Applications
Unspecified application
Species
Unspecified reactive species
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 39:1010428317701640 PubMed28475006
2017
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 49:65-74 PubMed27869826
2016
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 289:26302-13 PubMed25100728
2014
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroendocrinology 25:292-301 PubMed22935015
2012
Applications
Unspecified application
Species
Unspecified reactive species
International journal of cancer 128:487-91 PubMed20340132
2010
Applications
Unspecified application
Species
Unspecified reactive species
British journal of haematology 144:546-51 PubMed19055661
2008
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com